► Home ﹥About Us ﹥Management Team Ko-Chung Lin, PhD Founder and CEO Being the leading founder of PharmaEssentia, Dr. Lin is an accomplished scientist, receiving his Ph.D. from the University of Missouri, followed by postdoctoral research at the University of Michigan. With more than 20 years of successful experience in drug discovery and development, Dr. Lin was also the co-founder of the discovery chemistry team at Biogen, where he led the team to discover their first drug candidate that was later licensed to Merck Co. Prior to that, his work at Monsanto-Searle on HIV protease inhibitor project resulted in an AIDS drug on the market. In addition, he is also the holder of more than 40 patents. Ching-Leou Teng, PhD Executive Vice President, Operation & R & D Prior to joining the US Food and Drug Administration (FDA) as a reviewer in pharmacokinetics, Dr. Teng obtained her Ph.D. specializing in drug absorption from the University of Michigan, followed by two years of post doctoral research. Following her experience in the US FDA, Dr. Teng joined US-based ISIS Pharmaceuticals, focusing on new drug development, dosage form formulation, manufacturing and processing validation, CMC section, as well as preclinical studies for both IND application and NDA approvals. Jack Hwang, PhD Vice President, Development Chemistry Dr. Hwang obtained his PhD specializing in synthetic organic chemistry from the University of Pennsylvania. Prior to his joining PharmaEssentia, Dr. Hwang was the senior director at San Diego-based Optimer Pharmaceuticals. He also worked for Ligand Pharmaceuticals, Amgen and Array Biopharma after he earned his Ph.D. degree. In addition to these achievements, Dr. Hwang has authored 37 scientific papers and 17 patents. James Lee, Ph.D Executive Director, Analytical and QC Dr. Lee holds a Ph.D. specializing in analytical chemistry from the University of Michigan. Prior to joining PharmaEssentia, Dr. Lee has over 20 years of extensive industrial experience in analytical method development for small molecules, protein biologics in analysis and characterization as well as project management. His working experience includes Children’s Hospital of Philadelphia, Merck and Bayer where he focused on analytical method development, product characterization in support of R&D, process development, as well as quality control under cGMP/GLP. Shu-Fen Li, MBA Director, Business Development and Strategic Planning Holding a wealth of experience in international venture capital fund raising, marketing, product pricing, licensing and corporate strategic planning, Ms. Li began her career in Yuan-Ta Securities Group in Taiwan, followed by Siemens AG in Germany where she utilized her overseas education and experience. After leaving Siemens AG, she joined Financial Service International Corp. as well as Trade Compass, a Federal Express start-up, both located in the USA. In addition to her MBA from Seattle Pacific University, USA, Ms Li also studied at Harvard University where she focused on healthcare marketplace and general management-related courses between 2007 and 2008. Copyright © 2008 PharmaEssentia Corporation All Rights Reserved.